1932

Abstract

Although safe and effective agents are currently available to treat osteoporosis, fragility fractures remain a significant problem worldwide. Recent improvements in the understanding of the cellular, biochemical, and molecular pathways of bone biology have led to the development of newer agents to treat osteoporosis, which may lead to further improvements in outcomes. In this review, we summarize the most recent advances in the field, including new modes of administration of existing drug classes, various approaches to combination therapy, and drugs with novel mechanisms of action to treat osteoporosis.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-med-061709-145401
2011-02-18
2024-05-14
Loading full text...

Full text loading...

/content/journals/10.1146/annurev-med-061709-145401
Loading
/content/journals/10.1146/annurev-med-061709-145401
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error